Teva and Alvotech strike deal for 'increased involvement' at Alvotech's troubled Iceland site
Teva is taking Alvotech’s manufacturing troubles into its own hands after deficiencies at an Icelandic facility led to another rejection for the partners’ Humira biosimilar …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.